Skip to main content

Josep Castellví Vives

Institutions of which they are part

Translational Molecular Pathology
Vall Hebron Institut de Recerca

Josep Castellví Vives

Institutions of which they are part

Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Identificación de nuevas dianas para el tratamiento del cáncer basada en el estudio de factores cap-independientes activados en tumores malignos

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Vicente Peg Camara, Trond Aasen
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 9283
Reference: FMM-2011-11
Duration: 01/09/2011 - 31/08/2012

Identification of new molecules and mechanisms of myometrial infiltration and early diagnosis to improve survival in endometrial cancer

IP: Jaume Reventós Puigjaner
Collaborators: Maria Asuncion Perez Benavente, Eva Colas Ortega, Josep Castellví Vives
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 133100
Reference: SAF2011-26548
Duration: 01/01/2012 - 31/12/2014

Ministerio de Ciencia

Caracterización Molecular de los procesos de infiltración y diseminación tumorales y desarrollo de metástasis en cáncer de endometrio. Papel de RUNX1 en la promoción de las metástasis.

IP: Jaume Reventós Puigjaner
Collaborators: Josep Castellví Vives, Antonio Gil Moreno
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 96800
Reference: SAF2008-03996
Duration: 01/01/2009 - 31/12/2011

Ministerio de Ciencia

Correlación de la expresión de factores embudo 4EBP1, con la expresión de diferentes receptores epidérmicos: papel de HER3, HER2 y sus formas truncadas en diferentes tipos de tumor

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Josep Castellví Vives, Javier Hernandez Losa
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 75000
Reference: FMMA/13/2008
Duration: 30/07/2008 - 29/07/2011

Related news

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The multidisciplinary paper on papillary thyroid cancer has been considered the best original article of 2021 in the journal Endocrinología, Diabetes y Nutrición

Related professionals

Alba Torija Recasens

Alba Torija Recasens

Predoctoral researcher
Nephrology and kidney transplantation
Read more
Carmina Castellano Tejedor

Carmina Castellano Tejedor

Senior researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Concepció Jacobs Cachá

Concepció Jacobs Cachá

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Xavier Serra Ruiz

Xavier Serra Ruiz

Research technician
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.